---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-024575"
form_type: "8-K"
ticker: "HIT"
cik: "0002019505"
company_name: "Health In Tech, Inc."
filed_at: "2025-03-17T23:59:59+00:00"
generated_at: "2026-05-24T16:55:03.260284+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Health In Tech FY2024 revenue $19.5M (+1.8%); adj. EBITDA falls to $2.3M from $4.8M; leadership reshuffled

## Summary
- Full-year 2024 revenue $19.5M (+1.8% YoY); income from continuing ops $0.7M vs $2.5M in 2023.
- Q4 2024 revenue $4.9M vs $5.2M; net loss from continuing ops ($0.1M) vs income $1.0M; adjusted EBITDA $0.5M vs $1.0M.
- Cash $7.8M at Dec 31, 2024 (up from $2.4M); total liabilities $2.6M (down from $5.4M).
- Unaudited Jan-Feb 2025 revenue ~$5.7M, >50% YoY growth, exceeding entire Q1 2024.
- Leadership changes: Chris Kurtenbach promoted to COO; Dustin Plantholt named Chief Growth Officer; Jenni Guerrica CISO; Jonathan Del Lockett becomes Chief Strategy Officer.

## SEC filing metadata
- accession: 0001213900-25-024575
- form_type: 8-K
- ticker: HIT
- cik: 0002019505
- company_name: Health In Tech, Inc.
- filed_at: 2025-03-17T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2019505/000121390025024575/0001213900-25-024575-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2019505/000121390025024575/ea0234672-8k_health.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-024575
- JSON: https://secwatch.observer/filing/0001213900-25-024575.json
- Plain text: https://secwatch.observer/filing/0001213900-25-024575.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.